Brief: Sprint Bioscience Q2 operating result swings to profit SEK 4.1 mln
Aug 24 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q2 revenue 17.8 million Swedish crowns ($2.12 million) versus 1.1 million crowns year ago
* Q2 oper profit 4.1 million crowns versus loss 5.0 million crowns year ago
Source text for Eikon: ID:nWkrhw4980
Further company coverage: SPRINT.ST
($1 = 8.3885 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln